Overview
Introduction
Renal electrolyte management starts by deciding what an abnormal result represents: an immediate threat, a chronic consequence of reduced kidney function, or a reversible medica...
Renal electrolyte management starts by deciding what an abnormal result represents: an immediate threat, a chronic consequence of reduced kidney function, or a reversible medication or dietary effect. The same patient may have all three. A patient with advanced CKD taking ramipril and spironolactone develops a potassium of 6.8 mmol/L with peaked T waves. That finding takes priority over the slower problems of phosphate retention or metabolic acidosis because potassium is already disturbing myocardial electrical stability. Calcium is used to protect the myocardium, while other therapies shift or remove potassium. It does not make the potassium value normal. After the immediate threat is addressed, interpret sodium, bicarbonate, phosphate, calcium, magnesium, creatinine, and urine output as a connected pattern. Reduced filtration limits potassium, phosphate, acid, and free-water handling; medications can magnify those effects, and treatment can create new hazards such as hypoglycemia, fluid overload, overcorrection of sodium, or hypomagnesemia. Serial trends and the patient’s clinical state are more informative than an isolated laboratory value. Apply the current Canadian product monograph and local institutional protocol when selecting doses, access requirements, monitoring intervals,...